Alx Oncology Holdings (ALXO) Other Working Capital Changes (2020 - 2026)
Alx Oncology Holdings (ALXO) posted Other Working Capital Changes of -$418000.0 for Q1 2026, down 3.47% sequentially from -$404000.0 in Q4 2025, and up 17.55% YoY from -$355580.5 in Q1 2025.
Alx Oncology Holdings (ALXO) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Alx Oncology Holdings has reported Other Working Capital Changes for 7 years, with the latest figure at -$418000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 17.55% year-over-year to -$418000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.8 million (up 6.52% YoY) and the FY2025 annual result came in at -$1.9 million, up 7.77% from the prior year.
- Other Working Capital Changes retreated to -$418000.0 in Q1 2026 per ALXO's latest filing, from -$404000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $6.3 million in Q3 2025 and troughed at -$8.2 million in Q3 2024.
- A 5-year average of -$484058.8 and a median of -$12000.0 in 2025 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes jumped 94.89% in 2022, then sank 467.8% in 2023.
- Over 5 years, Other Working Capital Changes stood at -$141000.0 in 2022, then plunged by 159.57% to -$366000.0 in 2023, then tumbled by 35.52% to -$496000.0 in 2024, then climbed by 18.55% to -$404000.0 in 2025, then decreased by 3.47% to -$418000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$418000.0, -$404000.0, and -$479000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Alx Oncology Holdings | 270.90 Mn | 270.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -315,000.00 |
| Jun 30, 2026 | -315,000.00 |
| Jun 30, 2026 | -315,000.00 |
| Mar 31, 2026 | -418,000.00 |
| Mar 31, 2026 | -418,000.00 |
| Mar 31, 2026 | -418,000.00 |
| Dec 31, 2025 | -404,000.00 |
| Dec 31, 2025 | -404,000.00 |
| Dec 31, 2025 | -404,000.00 |
| Sep 30, 2025 | -479,000.00 |
| Sep 30, 2025 | -479,000.00 |
| Sep 30, 2025 | -479,000.00 |
| Jun 30, 2025 | -520,000.00 |
| Jun 30, 2025 | -520,000.00 |
| Jun 30, 2025 | -520,000.00 |
| Mar 31, 2025 | -507,000.00 |
| Mar 31, 2025 | -507,000.00 |
| Mar 31, 2025 | -507,000.00 |
| Dec 31, 2024 | -496,000.00 |
| Dec 31, 2024 | -496,000.00 |